Search research articles
Contact Us
Filters
Showing results (101-110 of 156) with videos related to
Page
of 16
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
September 14, 2001
High levels of hCG in choriocarcinoma can result in renal failure and a false-negative pregnancy test in men
T Meyer, L A Cole, P I Richman, et al.
British Journal of Obstetrics and Gynaecology
|
January 1, 1986
Developments in chemotherapy for medium- and high-risk patients with gestational trophoblastic tumours (1979-1984)
E S Newlands, K D Bagshawe, R H Begent, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 23, 2000
Surveillance for stage I testicular germ cell tumours: results and cost benefit analysis of management options
R Francis, M Bower, G Brunström, et al.
British Journal of Urology
|
June 1, 1986
Current optimum management of anaplastic germ cell tumours of the testis and other sites
E S Newlands, K D Bagshawe, R H Begent, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 16, 1998
Chemotherapy for gestational trophoblastic tumours hastens menopause by 3 years
M Bower, G J Rustin, E S Newlands, et al.
British Journal of Obstetrics and Gynaecology
|
September 1, 1995
Presentation and management of choriocarcinoma after nonmolar pregnancy
J A Tidy, G J Rustin, E S Newlands, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1993
Molecular and biological factors in the pathogenesis of ovarian cancer
J S Berek, O Martínez-Maza, T Hamilton, et al.
European Journal of Cancer & Clinical Oncology
|
June 1, 1988
Single agent etoposide in gestational trophoblastic tumours. Experience at Charing Cross Hospital 1978-1987
R N Hitchins, L Holden, E S Newlands, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1989
Use of CA-125 to predict survival of patients with ovarian carcinoma. North Thames Cooperative Group
G J Rustin, J N Gennings, A E Nelstrop, et al.
International Journal of Andrology
|
February 1, 1987
Treatment of patients with poor prognosis anaplastic germ cell tumours (AGCT) of the testis and other sites
E S Newlands, K D Bagshawe, R H Begent, et al.
Page
of 16
Search research articles
Search
Showing results (101-110 of 156) with videos related to
Sort By:
Page
of 16
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
September 14, 2001
High levels of hCG in choriocarcinoma can result in renal failure and a false-negative pregnancy test in men
T Meyer, L A Cole, P I Richman, et al.
British Journal of Obstetrics and Gynaecology
|
January 1, 1986
Developments in chemotherapy for medium- and high-risk patients with gestational trophoblastic tumours (1979-1984)
E S Newlands, K D Bagshawe, R H Begent, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 23, 2000
Surveillance for stage I testicular germ cell tumours: results and cost benefit analysis of management options
R Francis, M Bower, G Brunström, et al.
British Journal of Urology
|
June 1, 1986
Current optimum management of anaplastic germ cell tumours of the testis and other sites
E S Newlands, K D Bagshawe, R H Begent, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 16, 1998
Chemotherapy for gestational trophoblastic tumours hastens menopause by 3 years
M Bower, G J Rustin, E S Newlands, et al.
British Journal of Obstetrics and Gynaecology
|
September 1, 1995
Presentation and management of choriocarcinoma after nonmolar pregnancy
J A Tidy, G J Rustin, E S Newlands, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1993
Molecular and biological factors in the pathogenesis of ovarian cancer
J S Berek, O Martínez-Maza, T Hamilton, et al.
European Journal of Cancer & Clinical Oncology
|
June 1, 1988
Single agent etoposide in gestational trophoblastic tumours. Experience at Charing Cross Hospital 1978-1987
R N Hitchins, L Holden, E S Newlands, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1989
Use of CA-125 to predict survival of patients with ovarian carcinoma. North Thames Cooperative Group
G J Rustin, J N Gennings, A E Nelstrop, et al.
International Journal of Andrology
|
February 1, 1987
Treatment of patients with poor prognosis anaplastic germ cell tumours (AGCT) of the testis and other sites
E S Newlands, K D Bagshawe, R H Begent, et al.
Page
of 16